Mark O’Carroll
Impact in
-
- Cystic Fibrosis Research Advances
-
- Infections and bacterial resistance
Papers in
-
- Cystic Fibrosis Research Advances 7
- Tracheal and airway disorders 1
- Pleural and Pulmonary Diseases 1
- Surgery 6
- Transplantation: Methods and Outcomes 5
- Co-authors
- Theo P. Sloots (2 shared papers)Claire Elizabeth Wainwright (2 shared papers)Michael D. Nissen (2 shared papers)Ristan M. Greer (1 shared paper)Melanie W. Syrmis (2 shared papers)Scott Cameron Bell (3 shared papers)C. Coulter (2 shared papers)David G. Milne (1 shared paper)
- Journals
- Journal of Cystic Fibrosis (2 papers)European Respiratory Journal (1 paper)Microbiology Spectrum (1 paper)The Lancet Respiratory Medicine (1 paper)Laryngoscope Investigative Otolaryngology (1 paper)
- Partner nations
- New ZealandAustraliaUnited Kingdom
In The Last Decade
Mark O’Carroll
14 papers receiving 268 citations
Mark O’Carroll's Hit Papers
Peers
Comparison fields: 5 of 39
- Pulmonary and Respiratory Medicine 154
- Endocrinology 12
- Molecular Medicine 14
- Epidemiology 41
- Clinical Biochemistry 6
Countries citing papers authored by Mark O’Carroll
This map shows the geographic impact of Mark O’Carroll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark O’Carroll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark O’Carroll more than expected).
Fields of papers citing papers by Mark O’Carroll
This network shows the impact of papers produced by Mark O’Carroll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark O’Carroll. The network helps show where Mark O’Carroll may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark O’Carroll, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 97 | |
| 2 | Vanzacaftor–tezacaftor–deutivacaftor versus elexacaftor–tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 and VX20-121-103): results from two randomised, active-controlled, phase 3 trials Hit paper breakdown → | 2025 | 59 |
| 3 | 2003 | 57 | |
| 4 | 2011 | 24 | |
| 5 | 2012 | 9 | |
| 6 | 2024 | 8 | |
| 7 | 2023 | 5 | |
| 8 | 2018 | 4 | |
| 9 | 2013 | 3 | |
| 10 | 2024 | 3 | |
| 11 | 2008 | 2 | |
| 12 | Multi-resistant Pseudomonas aeruginosa (MRPA) in a large adult cystic fibrosis (CF) unit | 2003 | 1 |
| 13 | 2020 | 1 | |
| 14 | 2020 | 1 | |
| 15 | 2020 | 1 | |
| 16 | 2004 | 0 | |
| 17 | 2024 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2025 | 0 |
About Mark O’Carroll
Mark O’Carroll is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Medicine and Molecular Biology, having authored 19 papers that have together received 275 indexed citations. Recurring topics across this work include Cystic Fibrosis Research Advances (7 papers), Transplantation: Methods and Outcomes (5 papers), Bacterial biofilms and quorum sensing (2 papers), Cancer Immunotherapy and Biomarkers (1 paper), Tracheal and airway disorders (1 paper), Burkholderia infections and melioidosis (1 paper), Pleural and Pulmonary Diseases (1 paper) and Antibiotic Resistance in Bacteria (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (154 citations), Endocrinology (12 citations), Molecular Medicine (14 citations), Epidemiology (41 citations) and Clinical Biochemistry (6 citations). Mark O’Carroll has collaborated with scholars based in New Zealand, Australia and United Kingdom. Frequent co-authors include Theo P. Sloots, Claire Elizabeth Wainwright, Michael D. Nissen, Ristan M. Greer, Melanie W. Syrmis, Scott Cameron Bell, C. Coulter, David G. Milne, Aruni Seneviratna and Nicholas D. Child. Their work appears in journals such as Journal of Cystic Fibrosis, European Respiratory Journal, Microbiology Spectrum, The Lancet Respiratory Medicine and Laryngoscope Investigative Otolaryngology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.